Tag: distribution of Tislelizumab
Glenmark to sell BeiGene’s oncology medicines, Tislelizumab and Zanubrutinib in India
Under this strategic collaboration, Glenmark will be responsible for locally required development, registration and distribution providing access to BeiGene's innovative oncology medicines for cancer patients across India